Investigation of cultivation conditions for capsular polysaccharide production by Streptococcus pneumoniae serotype 14
Full Text
Reprint PDF

Keywords

polysaccharide capsular
vaccine
Streptococcus pneumoniae

How to Cite

1.
Moura Leal M de L, Gomes Pereira D da S, Jessouroun E, Peixoto Gimenes Couto MA, Pereira Jr N. Investigation of cultivation conditions for capsular polysaccharide production by Streptococcus pneumoniae serotype 14. Electron. J. Biotechnol. [Internet]. 2011 Sep. 15 [cited 2024 Sep. 17];14(5). Available from: https://preprints.pucv.cl/index.php/ejbiotechnology/article/view/v14n5-6

Abstract

Streptococcus pneumoniae (pneumococcus) is among the most significant causes of bacterial disease in humans. Capsular polysaccharide (CPS) production is essential for pneumococcal virulence. Pneumococcal CPS has been widely used as vaccine antigen. This study is focused on the influence of culture conditions of Streptococcus pneumoniae serotype 14 as for developing an industrial method for polysaccharide production. The pH proved to be a highly important variable in batchwise culture. Using the pH control all glucose added was consumed resulting in a four-fold increase in polysaccharide productivity relative to cultivation without pH control. S. pneumoniae is a lactic acid bacterium, so named for its primary metabolic byproduct (lactate), which has an inhibitory effect on cell growth in concentrations ranging from 4 to 5 g/L. An increase of 30% in polysaccharide productivity was observed using glucose pulses with 5.5 hrs of growth, resulting in a maximum polysaccharide concentration of 185.2 mg/L. Our data suggest the possibility of using a medium of non-animal origin and employing pH control for the cultivation of pneumococcus to produce a polysaccharide vaccine.

Full Text
Reprint PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.